Atlas Trials

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Clinical trial NCT01219855 · COMPLETED

Trial details

NCT number
NCT01219855
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chronic Kidney DiseaseSecondary HyperparathyroidismVitamin D Insufficiency
Start date
2010-10-01
Primary completion
2011-11-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.